Schachter I, Antignani P L
UOC di Angiologia, Azienda Ospedaliera S. Giovanni-Addolorata, Roma.
Minerva Cardioangiol. 2006 Dec;54(6):811-4.
The aim of the study is to evaluate the degree of the relationship between dysthyroidism and connective pathology, both autoimmune diseases, presenting, sometimes, an early common symptom: the Raynaud phenomenon.
We studied 30 patients subdivided as follows: 18 affected by mixed connective pathology, 6 by scleroderma, 2 by CREST, 4 by scleroderma and Sjogren syndrome. We focused our attention on the chronology and the duration of the diagnosis, correlated to the laboratory parameters and the hypothesis of the pathogenetic pathway.
36.6% were positive to both the pathologies. One of the 11 patients resulted positive to hyperthyroidism and mixed connective, 10 patients resulted positive to hyperthyroidism subdivided in: 6 affected by sclerodermia and by 4 sclerodermia and S. of Sjogren. All the patients were positive to ANA without correlation between those values and the microsomal or antithyreoglobulin antibodies: the last two were present in 33%. The laboratory parameters indicating the inflammatory state were in the normal range, a light hypercholesterolemia was found in all patients.
There is a suggestive relationship between the connective pathology and dysthyroidism,therefore it can be useful to evaluate always the association of both pathologies for the future identification of the immunogenetic alteration factors, the evaluation of the composition and the turnover of the collagen, subdividing the patients in relation to the clinical and the laboratory parameters, follow up to middle and long term.
本研究旨在评估甲状腺功能障碍与结缔组织病理(两者均为自身免疫性疾病)之间的关联程度,这两种疾病有时会出现一个早期共同症状:雷诺现象。
我们研究了30例患者,分组如下:18例患有混合性结缔组织病,6例患有硬皮病,2例患有CREST综合征,4例患有硬皮病和干燥综合征。我们关注诊断的时间顺序和持续时间,并将其与实验室参数以及发病机制途径的假设相关联。
36.6%的患者两种病症均呈阳性。11例患者中有1例甲状腺功能亢进症和混合性结缔组织病呈阳性,10例甲状腺功能亢进症呈阳性,细分如下:6例患有硬皮病,4例患有硬皮病和干燥综合征。所有患者抗核抗体均呈阳性,这些值与微粒体或抗甲状腺球蛋白抗体之间无相关性:后两者在33%的患者中出现。表明炎症状态的实验室参数在正常范围内,所有患者均发现轻度高胆固醇血症。
结缔组织病理与甲状腺功能障碍之间存在提示性关联,因此,为了未来识别免疫遗传改变因素、评估胶原蛋白的组成和更新,根据临床和实验室参数对患者进行细分,并进行中长期随访,始终评估两种病症的关联可能会有所帮助。